| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aberrant allele-switch imprinting of a novel IGF1R intragenic antisense non-coding RNA in breast cancers
|
Kang, Lihua
|
|
2015
|
51 |
2 |
p. 260-270
11 p.
|
artikel
|
| 2 |
ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth
|
Dhyani, Anamika
|
|
2015
|
51 |
2 |
p. 252-259
8 p.
|
artikel
|
| 3 |
Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma
|
Hokuto, Daisuke
|
|
2015
|
51 |
2 |
p. 157-165
9 p.
|
artikel
|
| 4 |
Comparison of Response Evaluation Criteria in Solid Tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: A retrospective analysis
|
Taieb, Sophie
|
|
2015
|
51 |
2 |
p. 202-209
8 p.
|
artikel
|
| 5 |
Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer
|
Vassal, Gilles
|
|
2015
|
51 |
2 |
p. 218-224
7 p.
|
artikel
|
| 6 |
Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?
|
Ben Arush, M.
|
|
2015
|
51 |
2 |
p. 193-201
9 p.
|
artikel
|
| 7 |
Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials
|
Faron, Matthieu
|
|
2015
|
51 |
2 |
p. 166-176
11 p.
|
artikel
|
| 8 |
Management of sporadic desmoid-type fibromatosis: A European consensus approach based on patients’ and professionals’ expertise – A Sarcoma Patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative
|
Kasper, B.
|
|
2015
|
51 |
2 |
p. 127-136
10 p.
|
artikel
|
| 9 |
Mortality within 30days following systemic anti-cancer therapy, a review of all cases over a 4year period in a tertiary cancer centre
|
Khoja, L.
|
|
2015
|
51 |
2 |
p. 233-240
8 p.
|
artikel
|
| 10 |
Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumours
|
Spicer, J.
|
|
2015
|
51 |
2 |
p. 137-145
9 p.
|
artikel
|
| 11 |
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours
|
Weihrauch, Martin R.
|
|
2015
|
51 |
2 |
p. 146-156
11 p.
|
artikel
|
| 12 |
Recurrence and cancer-specific survival according to the expression of IL-4Rα and IL-13Rα1 in patients with oral cavity cancer
|
Kwon, Minsu
|
|
2015
|
51 |
2 |
p. 177-185
9 p.
|
artikel
|
| 13 |
Risk factors for local recurrence in Wilms tumour and the potential influence of biopsy – The United Kingdom experience
|
Irtan, S.
|
|
2015
|
51 |
2 |
p. 225-232
8 p.
|
artikel
|
| 14 |
Sporadic extra abdominal wall desmoid-type fibromatosis: Surgical resection can be safely limited to a minority of patients
|
Colombo, C.
|
|
2015
|
51 |
2 |
p. 186-192
7 p.
|
artikel
|
| 15 |
Tenosynovial giant cell tumour/pigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitors
|
Palmerini, Emanuela
|
|
2015
|
51 |
2 |
p. 210-217
8 p.
|
artikel
|
| 16 |
Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registries
|
Anttila, Ahti
|
|
2015
|
51 |
2 |
p. 241-251
11 p.
|
artikel
|
Tijdschrift beschrijving